Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study
- DOI
- 10.1016/j.annonc.2026.07.413
- Published
- 2026-08
- Container
- Annals of Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.annonc.2026.07.413,
title = {Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study},
author = {R-H. Xu and B.C. Cho and M. Chen and K. Muro and L. Wyrwicz and B. Li and S. Gao and C. Hsu and A. Turpin and F. Lordick and E. Cha and Q. Wu and S. Kim and J. Cai and L. Zhang and J. Fan and L. Wang and K. Sully and L. Wang and K. Goodman and M.A. Shah and I. Chau},
year = {2026},
journal = {Annals of Oncology},
doi = {10.1016/j.annonc.2026.07.413},
url = {https://doi.org/10.1016/j.annonc.2026.07.413}
}RIS
TY - JOUR TI - Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study AU - R-H. Xu AU - B.C. Cho AU - M. Chen AU - K. Muro AU - L. Wyrwicz AU - B. Li AU - S. Gao AU - C. Hsu AU - A. Turpin AU - F. Lordick AU - E. Cha AU - Q. Wu AU - S. Kim AU - J. Cai AU - L. Zhang AU - J. Fan AU - L. Wang AU - K. Sully AU - L. Wang AU - K. Goodman AU - M.A. Shah AU - I. Chau PY - 2026 JO - Annals of Oncology DO - 10.1016/j.annonc.2026.07.413 UR - https://doi.org/10.1016/j.annonc.2026.07.413 ER -
APA
Xu, R., Cho, B., Chen, M., Muro, K., Wyrwicz, L., Li, B., Gao, S., Hsu, C., Turpin, A., Lordick, F., Cha, E., Wu, Q., Kim, S., Cai, J., Zhang, L., Fan, J., Wang, L., Sully, K., Wang, L., Goodman, K., Shah, M., & Chau, I. (2026). Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study. Annals of Oncology. https://doi.org/10.1016/j.annonc.2026.07.413
Source records
- crossref · retrieved 2026-09-25T20:43:14.293Z